| Original language | English |
|---|---|
| Pages (from-to) | 394-400 |
| Journal | Journal of Cancer Science & Therapy |
| Volume | 4 |
| Issue number | 12 |
| DOIs | |
| Publication status | Published - 2012 |
Cite this
}
Safety and Efficacy of Radioimmunotherapy with 90Yttrium-rituximab in Patients with Relapsed CD20+ B cell Lymphoma: A Feasibility Study. / Vaes, M.; Bron, D.; Vugts, D.J.; Paesmans, M.; Meuleman, M.; Ghanem, G.; Guiot, T.; Vanderlinden, B.; Thielemans, K.; van Dongen, G.A.M.S.; Flamen, P.; Muylle, K.
In: Journal of Cancer Science & Therapy, Vol. 4, No. 12, 2012, p. 394-400.Research output: Contribution to journal › Article › Academic
TY - JOUR
T1 - Safety and Efficacy of Radioimmunotherapy with 90Yttrium-rituximab in Patients with Relapsed CD20+ B cell Lymphoma: A Feasibility Study
AU - Vaes, M.
AU - Bron, D.
AU - Vugts, D.J.
AU - Paesmans, M.
AU - Meuleman, M.
AU - Ghanem, G.
AU - Guiot, T.
AU - Vanderlinden, B.
AU - Thielemans, K.
AU - van Dongen, G.A.M.S.
AU - Flamen, P.
AU - Muylle, K.
PY - 2012
Y1 - 2012
U2 - 10.4172/1948-5956.1000173
DO - 10.4172/1948-5956.1000173
M3 - Article
VL - 4
SP - 394
EP - 400
JO - Journal of Cancer Science & Therapy
JF - Journal of Cancer Science & Therapy
SN - 1948-5956
IS - 12
ER -